Fasting glucose levels decreased, and insulin resistance improved in both Type 2 diabetes and obesity patients
We go over your health history, the medications you take, your weight-related concerns, and whether you meet the criteria to begin
At DiscovHER Health, you will receive ongoing support throughout your treatment journey
Youre receiving: The same expert medical evaluation The same FDA-approved GLP-1 medications (Ozempic/semaglutide, Mounjaro/tirzepatide, Wegovy, Zepbound) The same personalized treatment plan The same ongoing monitoring and support The only difference
Tolerability and Weight Reduction of Tirzepatide in Adults with Obesity or Overweight in SURMOUNT-1 trial In this medfyle In SURMOUNT-1 trial, tirzepatide-induced weight reduction seems unrelated to gastrointestinal adverse events This Medfyle was published more than two years ago
Study findings have methods, limitations, controls, and model conditions